| Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden … L Arnheim-Dahlström, B Pasternak, H Svanström, P Sparén, A Hviid Bmj 347, 2013 | 384 | 2013 |
| Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study P Ueda, H Svanström, M Melbye, B Eliasson, AM Svensson, S Franzén, ... bmj 363, 2018 | 351 | 2018 |
| Use of azithromycin and death from cardiovascular causes H Svanström, B Pasternak, A Hviid New England Journal of Medicine 368 (18), 1704-1712, 2013 | 331 | 2013 |
| Risk of major congenital malformations in relation to maternal overweight and obesity severity: cohort study of 1.2 million singletons M Persson, S Cnattingius, E Villamor, J Söderling, B Pasternak, ... bmj 357, 2017 | 299 | 2017 |
| Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease NN Andersen, B Pasternak, S Basit, M Andersson, H Svanström, ... Jama 311 (23), 2406-2413, 2014 | 290 | 2014 |
| Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study B Pasternak, M Inghammar, H Svanström Bmj 360, 2018 | 258 | 2018 |
| Ondansetron in pregnancy and risk of adverse fetal outcomes B Pasternak, H Svanström, A Hviid New England Journal of Medicine 368 (9), 814-823, 2013 | 258 | 2013 |
| Use of azathioprine and the risk of cancer in inflammatory bowel disease B Pasternak, H Svanström, K Schmiegelow, T Jess, A Hviid American journal of epidemiology 177 (11), 1296-1305, 2013 | 249 | 2013 |
| Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects B Pasternak, A Hviid Jama 304 (8), 859-866, 2010 | 249 | 2010 |
| Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism A Hviid, M Melbye, B Pasternak New England Journal of Medicine 369 (25), 2406-2415, 2013 | 236 | 2013 |
| Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system NM Scheller, H Svanström, B Pasternak, L Arnheim-Dahlström, ... Jama 313 (1), 54-61, 2015 | 230 | 2015 |
| Use of proton-pump inhibitors in early pregnancy and the risk of birth defects B Pasternak, A Hviid New England Journal of Medicine 363 (22), 2114-2123, 2010 | 214 | 2010 |
| Common variants associated with general and MMR vaccine–related febrile seizures B Feenstra, B Pasternak, F Geller, L Carstensen, T Wang, F Huang, ... Nature genetics 46 (12), 1274-1282, 2014 | 178 | 2014 |
| Metalloproteinases and their inhibitors—diagnostic and therapeutic opportunities in orthopedics B Pasternak, P Aspenberg Acta orthopaedica 80 (6), 693-703, 2009 | 174 | 2009 |
| Use of calcium channel blockers and Parkinson’s disease B Pasternak, H Svanström, NM Nielsen, L Fugger, M Melbye, A Hviid American journal of epidemiology 175 (7), 627-635, 2012 | 173 | 2012 |
| Risk of adverse fetal outcomes following administration of a pandemic influenza A (H1N1) vaccine during pregnancy B Pasternak, H Svanström, D Mølgaard-Nielsen, TG Krause, HD Emborg, ... Jama 308 (2), 165-174, 2012 | 152 | 2012 |
| Use of oral fluconazole during pregnancy and the risk of birth defects D Mølgaard-Nielsen, B Pasternak, A Hviid New England Journal of Medicine 369 (9), 830-839, 2013 | 145* | 2013 |
| Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark B Pasternak, H Svanström, D Mølgaard-Nielsen, TG Krause, HD Emborg, ... Bmj 344, 2012 | 143 | 2012 |
| Metoclopramide in pregnancy and risk of major congenital malformations and fetal death B Pasternak, H Svanström, D Mølgaard-Nielsen, M Melbye, A Hviid Jama 310 (15), 1601-1611, 2013 | 128 | 2013 |
| Association between use of oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth D Mølgaard-Nielsen, H Svanström, M Melbye, A Hviid, B Pasternak Jama 315 (1), 58-67, 2016 | 127 | 2016 |
